The Global Fund has Released its 2017 Results Report . They have also included supporting documents including key messages, and social media shareables .
“Smart, effective health investments through the Global Fund have saved 27 million lives – proof that global commitment can achieve remarkable success against the world’s deadliest infectious diseases.”
GFAN Supporting Materials:
Social Media Samples : Facebook, Twitter
Sharables: “The Global Fund has saved 27 million lives. I am one”
Suggested Talking Points to Complement the Global Fund Points:
Work done through the efforts of the Global Fund and its partners has saved 27 million lives, this is proof of the effectiveness of the global commitment to ...
The 2016 MOPAN 3.0 assessment finds that the Global Fund provides strong global leadership for the response to HIV and AIDS, tuberculosis and malaria. While this assessment reveals some areas where performance could be strengthened and improved, the overall conclusion is that the Global Fund fully meets the requirements of an effective multilateral organisation. It is fit for purpose and able to adapt to future needs.
Global Health Initiatives (GHIs) respond to high-impact communicable diseases in resource-poor countries, including health systems support, and are major actors in global health. GHIs could play an important role in countries affected by armed conflict given these countries commonly have weak health systems and a high burden of communicable disease. The aim of this study is to explore the influence of two leading GHIs, the Global Fund and the GAVI Alliance, on the health systems of conflict-affected countries.
There is a limited evidence-base on the influence of GHIs on health systems of conflict-affected countries. The findings suggest that GHIs are increasingly investing in conflict-affected countries which has helped to rapidly scale up health services, strengthen human resources, improve procurement, and develop guidelines and protocols. Negative influences include distorti...
Publisher: The Lancet , Volume 3, No. 2, e75–e77, February 2015
In June, 2014, the Global Fund to Fight AIDS, Tuberculosis, and Malaria completed its support for operations in China. The 10-year partnership between China and the Fund measurably improved China’s management of the three diseases, but it also created benefits that extend far beyond the metrics usually used to assess public health programmes. These benefits include deeper engagement with civil society organizations, stronger public health systems, and the implementation of innovative approaches for disease management.
Publisher: Zelman B, Kiszewski A, Cotter C, Liu J (2014) PLoS ONE (12): e115714. doi:10.1371/journal.pone.0115714
International financing for malaria increased more than 18-fold between 2000 and 2011; the largest source came from The Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund). Countries have made substantial progress, but achieving elimination requires sustained finances to interrupt transmission and prevent reintroduction. Since 2011, global financing for malaria has declined, fueling concerns that further progress will be impeded, especially for current malaria-eliminating countries that may face resurgent malaria if programs are disrupted.
Although external donor funding, particularly from the Global Fund, has been key for many malaria-eliminating countries, sustained and sufficient financing is critical for furthering global malaria elimination. Projected cost estimates for elimination provide policymakers with ...
Publisher: Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
The Global Fund was designed to pursue its mission through a partnership model, relying on local leaders, bilateral organizations, the private sector, technical partners, civil society organizations and advocates of public health, all of whom are essential to continued success. This paper, published in September 2014, highlights the different roles and responsibilities — as well as the shared goals and priorities — of the Global Fund and its U.S. bilateral partners.